I think others have mentioned this previously, but good cancer results will likely improve HIV market penetration faster also. Anyone on the fence of whether to switch treatments would likely do so if it can also prevent cancer and other indications. Hoping $500M inventory isn’t going to be enough once we get combo approval.

Time to inject! Hopefully we get this PR tomorrow or soon!